Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) traded up 21.2% on Friday . The stock traded as high as C$0.21 and last traded at C$0.20. 292,294 shares traded hands during mid-day trading, a decline of 46% from the average session volume of 538,273 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Stock Performance
The stock has a market cap of C$27.89 million, a price-to-earnings ratio of -20.00 and a beta of 0.32. The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21. The firm has a fifty day simple moving average of C$0.10 and a 200-day simple moving average of C$0.07.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Read More
- Five stocks we like better than Voyageur Pharmaceuticals
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- The 3 Best Fintech Stocks to Buy Now
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
